Communicated by Alexander G. Bearn, April 1, 1982 ABSTRACT Rabbits fed a wheat starch/casein diet develop a marked hypercholesterolemia accompanied by a decrease in the number of EDTA-sensitive binding sites on plasma membrane fractions of the liver for low density lipoproteins (LDL) and 13-migrating very low density lipoproteins
a recirculating system. The rate of catabolism was measured from the increment of nonprotein-bound radioiodine in the perfusate. The receptor-dependent catabolism of LDL by the liver was calculated from the difference ofhepatic catabolism of 125I-LDL and catabolism of LI-labeled cyclohexanedione-modified LDL, which does not bind to LDL receptors. The data show that about 74% of LDL catabolized by perfused livers from chow-fed rabbits is through the receptor-dependent pathway and 26% is through the receptor-independent pathway. In rabbits fed a cholesterol diet, the hepatic catabolism of 125I-LDL is reduced, and the receptordependent catabolism of 125I-LDL is abolished. In rabbits fed the wheat starch/casein diet, the receptor-dependent catabolism of 125I-LDL is reduced by 40% when compared with hepatic catabolism in chow-fed rabbits. Perfused livers from rabbits fed the wheat starch/casein diet supplemented with 1% cholestyramine show a 5.4-fold increase of receptor-dependent catabolism of 125I-LDL when compared with that of livers from rabbits fed the wheat starch/casein diet alone. Thus, these studies demonstrate that the change in the number ofrabbit hepatic membrane LDL receptors induced by dietary manipulation and drugs is correlated to the functional rate of removal of LDL by the liver.
In cultured extrahepatic cells, low density lipoproteins (LDL) are taken up by the cells after binding to the high-affinity receptor on the cellular surface. The activity of the LDL receptor is regulated by the concentration of LDL apolipoprotein in the culture medium (1) . Several lines of evidence suggest that the LDL receptor is involved in the catabolism of LDL in vivo. Patients with homozygous familial hypercholesterolemia, who have elevated plasma LDL concentration, lack the high-affinity LDL receptor in their cultured skin fibroblasts (2) . Shepherd et al. (3) showed that in heterozygous familial hypercholesterolemia, the removal of lmI-labeled LDL ('2I-LDL) from plasma by the receptor-dependent pathway is reduced. Thompson et al. (4) recently reported that in homozygous familial hypercholesterolemia, the removal of 125I-LDL by the receptordependent pathway is essentially abolished.
Cholesterol, the major component of LDL, is metabolized mainly by the liver. There is ample evidence that suggests that a receptor similar to that found in extrahepatic tissue also exists on the plasma membranes of the liver. Administration of pharmacological doses of 17a-ethinyl estradiol to rats increases the number of high-affinity binding sites for LDL on the liver membranes (5) , and the increased number ofbinding sites is accompanied by increased hepatic catabolism of 125I-LDL in isolated perfused rat livers (6) . A high-affinity binding site for LDL is also present in cultured pig (7) and rabbit hepatocytes (8) and in liver membranes prepared from dogs (9, 10) and rabbits (11) .
The rabbit is a suitable animal model for the study of lipoprotein metabolism. Recently, the Watanabe heritable hyperlipidemic (WHHL) rabbit line was discovered and found to be a useful model for the study of lipoprotein metabolism in familial hypercholesterolemia (12) . Homozygous WHHL rabbits have greatly reduced numbers of LDL receptor in both cultured fibroblasts (13) and hepatic membranes (11) . Normal rabbits also can become hypercholesterolemic ifthey are fed either a cholesterol diet (14) or a cholesterol-free wheat starch/casein diet (15) .
The hepatic LDL receptor in normal rabbits can be regulated by the addition ofdietary constituents to the animal diet. Feeding rabbits a cholesterol diet caused reduced activity of hepatic LDL receptor (16 
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months. The composition of the wheat starch/casein diet is as described (18) .
Preparation of Lipoproteins. LDL (1.02 < p < 1.063 g/ml) and high density lipoproteins (HDL) (1.063 < p < 1.21 g/ml) were isolated from the plasma of chow-fed rabbits by sequential ultracentrifugation (19) and labeled with 1"I by a modification (20) (22) . On agarose gel electrophoresis (pH 8.6), the modified LDL migrated more rapidly as a homogenous band than did native LDL.
Catabolism of Lipoproteins by Perfused Rabbit Livers. Liver perfusion was carried out in pairs of rabbits by the in situ perfusion method for rat livers of Mortimore (23) and modified by Hamilton et al. (24) with a "lung" of silastic tubing for gas exchange (25) . The apparatus was scaled up to accommodate rabbits. Liver donors were lightly anesthesized by intravenous injection of Nembutal (Abbott; 0.5 mg/kg of body weight). The peritoneal cavity was opened, and a ligature was placed around the vena cava between the liver and kidney. The portal vein was then cannulated with a Quik-Cath catheter (14 gauge x 5.1 cm, Travenol Laboratories, Dallas, TX). The thorax was opened, and another catheter was placed in the inferior vena cava through the right atrium. The ligature placed around the vena cava between the liver and kidney was tied off. The liver was first flushed with 200 ml ofperfusate with washed (four times) rabbit erythrocytes at a hemotocrit of 10% in Krebs-Ringer bicarbonate buffer with glucose (100 mg/dl) and then was perfused with 100 ml ofperfusate containing rabbit erythrocytes at hematocrit 22% in a recirculating system at 37°C at a perfusion rate of 50 ml/min. The perfusate was equilibrated with 95% 02/5% CO2 at pH 7.4. The 1"I-labeled lipoproteins were added to the perfusate after a "recovery" period of 15 min. The rate ofcatabolism of 1"I-labeled lipoproteins by the liver was measured by the production of trichloroacetic acid-soluble 1"I in perfusateplasma (20) . Because the production of trichloroacetic acid-soluble "I in the perfusate-plasma is curvilinear, fractional catabolic rate (FCR) of '"I-LDL by perfused livers was calculated from the period of constant production of total trichloroacetic acid-soluble '25I from 125I-LDL (from 0.5 to 1.5 hr ofperfusion).
Chemical Analysis. Protein was determined by a modified procedure of Lowry with bovine serum albumin as standard (26) . Serum cholesterol concentration was determined by the cholesterol oxidase method with the Agent assay reagent from Abbott Laboratories.
RESULTS
Rabbits fed a wheat starch/casein diet developed marked hypercholesterolemia. After 30 days on the diet, the average serum cholesterol level of eight rabbits was about 175 mg/dl. In a previous study, serum cholesterol increased from an average of 50 mg/dl to 175 mg/dl with =76% of the total cholesterol in the LDL fraction (1.006 < p < 1.063 g/ml) (18) . The rate of appearance of trichloroacetic acid-soluble '25I in liver perfusates is shown in Fig. 1 . In livers from chow-fed rabbits, production of nonprotein-bound 1"I increased linearly with time in the perfusate after a 15-min latent period (Fig. 1A ). This latent period is similar to that observed in isolated perfused rat liver studies (6) . After 4 hr of perfusion, 9% of the added '"I-LDL was catabolized by the perfused chow-fed rabbit livers.
It has been shown that modification of the arginyl-residues of LDL by 1,2-cyclohexanedione abolishes its ability to bind to high-affinity sites for LDL in cultured human fibroblasts (22) and that the removal of "I-labeled CHD-LDL (125I-CHD-LDL) in humans (3) and in rabbits (17) is only by the receptorindependent pathway. Thus, we studied the rate of catabolism of lipoproteins by the hepatic receptor-independent pathway by measuring the rate of catabolism of CHD-LDL. After 4 hr, about 3% of the 125I-CHD-LDL in the perfusates was catabolized by the receptor-independent liver from chow-fed rabbits (Fig. 1A) . Shepherd et al have shown that rabbits fed a diet containing cholesterol resulted in a 90% suppression ofreceptor-mediated LDL uptake into liver, kidney, heart, lung, spleen, and gonads (27) . Kovanen et al. (16) also have demonstrated that the hepatic LDL receptor was suppressed in rabbits fed a cholesterol diet. To study the regulation of hepatic LDL receptor in rabbits, we studied the catabolism of 125I-LDL by perfused livers from rabbits that had been fed a cholesterol diet and whose serum cholesterol concentrations were >1,000 mg/dl. The rate of catabolism of 125I-LDL by perfused livers from cholesterol-fed rabbits was markedly reduced, whereas the hepatic catabolism of 125I-CHD-LDL was not altered by the cholesterol feeding (Fig. 1B) .
Rabbits fed a wheat starch/casein diet develop hypercholesterolemia accompanied by suppression of the hepatic EDTAsensitive binding sites for 125I-LDL and 125I-labeled ,-migrating very low density lipoproteins ('"I-P-VLDL) (18) . The rate of catabolism of 125I-LDL (receptor-dependent and receptorindependent) was reduced by 40% by the livers from rabbits fed this diet ( Fig. 2A) compared to that seen in chow-fed rabbits (Fig. 1A) .
Supplementing the wheat starch/casein diet with 1% cholestyramine has resulted in lower levels of serum cholesterol (the average serum cholesterol level of eight rabbits was 45 mg/dl) and increased the rate of removal of 125I-LDL from plasma and the induction of hepatic EDTA-sensitive binding sites for 125I-LDL and 125I-,/3VLDL (18) . The rate ofcatabolism of 125I-LDL was markedly increased in livers from rabbits fed the wheat starch diet supplemented with 1% cholestyramine (Fig. 2B) . The increased hepatic catabolism of125I-LDL by cholestyramine treatment is specifically for the receptor-dependent catabolism because the hepatic catabolism of 125I-CHD-LDL was not affected in this system (Fig. 2B) .
The specificity of the cholestyramine effects was studied by determining the catabolism of 125I-HDL by the perfused rabbit livers. HDL was prepared from rabbit plasma and was free of apolipoprotein E as judged by visual inspection ofan overloaded 10% polyacrylamide gel that had been electrophoresed in the presence of 0.2% sodium dodecyl sulfate. The catabolic rate of 125I-labeled HDL was essentially identical in perfused livers from rabbits fed either the wheat starch/casein diet alone or the diet supplemented with 1% cholestyramine (Fig. 3) . Table 1 summarizes the FCR of 125I-LDL by perfused rabbit livers determined from the data in Figs. 1-3 . In chow-fed rabbits, -74% of LDL catabolized by the liver is through the re- Wheat starch/casein with cholestyramine 9.8 0.8 9.0 * Total FCR is estimated from the period of constant production of total trichloroacetic acid-soluble 125I from 125I-LDL. t Receptor-independent FCR is estimated from the period of constant production of total trichloroacetic acid-soluble 125I from 125I-CHD-LDL.
DISCUSSION
* Receptor-dependent FCR is calculated from the difference of total FCR and receptor-independent FCR. ceptor-dependent pathway and 26% is through the receptorindependent pathway. Feeding the wheat starch/casein diet resulted in 40% reduction of receptor-dependent catabolism of LDL. Inclusion of 1% cholestyramine in the wheat starch/casein diet caused increased hepatic catabolism of 125I-LDL. Furthermore, only the receptor-dependent catabolism of 125I-LDL increased 5.4-fold, whereas the receptor-independent catabolism was not changed. The data also show that only the receptordependent catabolism of 125I-LDL by rabbit livers is subject to regulation by the dietary manipulations of the animal.
Our data from a different methodology are in reasonable agreement with those of Slater et al (17) . They demonstrated that, in rabbits fed a chow diet, human 125I-LDL is cleared from plasma by a receptor-dependent pathway and that the rate of clearance is stimulated by the inclusion ofcholestyramine in the diet. Furthermore, the major site of accumulation of label and the only organ where accumulation was stimulated by cholestyramine is the liver.
Rabbits fed the wheat starch/casein diet develop hypercholesterolemia and down-regulation of the hepatic EDTA-sensitive binding site for LDL and f-VLDL, yet the EDTA-resistant binding site and the nonspecific binding site are not affected by the diet (18) . Whether the observed receptor-dependent catabolism of 15I-LDL by the perfused livers from the wheat starch/casein-fed rabbits represents the catabolism through the EDTA-resistant binding site or through the small amounts of residual EDTA-sensitive binding site remains to be determined.
The mechanisms by which cholestyramine promotes hepatic LDL catabolism in rabbits fed the wheat starch/casein diet is not known. Because the wheat starch/casein diet is known to decrease the fecal excretion of bile acids in rabbits (15) , the addition of a bile acid sequestrant to the diet may promote the excretion of bile acids, thereby increasing the demand for cholesterol for bile acid synthesis in the liver. This demand can be supplied either by an increased level of de novo synthesis or from plasma LDL. In in vitro studies, we have demonstrated that cholestyramine induces the hepatic EDTA-sensitive binding site for 125I-LDL to a level that is the same as that of liver membranes from rabbits fed chow diet (18) . Moreover, the dissociation constant for 125I-LDL binding to liver membranes from rabbits fed chow diet is the same as that of liver membranes from the cholestyramine-treated rabbits. Yet the hepatic receptor-dependent catabolism of 1"I-LDL by the cholestyramine-treated rabbits is 3 times greater than that by the chowfed rabbits. Because the rabbits used in this study were different from those used in previously reported binding studies, the discrepancy between the two studies could be attributed to individual variations between rabbits. In rats treated with 17a-ethinyl estradiol, the increased hepatic catabolism of '25I-LDL Proc. Natl. Acad. Sci. USA 79 (1982) is accompanied with increased binding capacity of 125I-LDL to liver membranes (5, 6) . Whether cholestyramine has any effect on the intracellular degradation of LDL-e.g., promotes the recycling of LDL receptor and increases the levels of cholesterol 7a-hydroxylase or 3-hydroxy-3-methylglutaryl-CoA reductase, etc.-in this system needs investigation.
Recently, WHHL rabbits have been used as the animal model for the study of lipoprotein metabolism in familial hypercholesterolemia (12) . The homozygous WHHL rabbits resemble their human counterparts in having elevated plasma LDL cholesterol (450-855 mg/dl) (13) and having a reduced number of the classic LDL receptor in their fibroblasts in culture (13) . Furthermore, the EDTA-sensitive binding site for 125I-LDL and 125I-f-VLDL is reduced in liver membranes of the WHHL rabbits (11) . The receptor-dependent degradation of 125I-LDL is also lacking in cultured hepatocytes of the WHHL rabbits (28) . However, the total degradation of '"I-LDL by the cultured hepatocytes from the WHHL rabbits is somewhat increased rather than decreased (28) . Because 6% of the LDL receptor activity remained in the WHHL rabbit fibroblasts (13) and small amounts of residual EDTA-sensitive binding remained in the liver membranes from WHHL rabbits (11) , it would be of interest to investigate if the homozygous WHHL rabbits respond to cholestyramine treatment by increasing the hepatic catabolism of LDL. Cholesterol is excreted from the body by conversion to bile acids in the liver. Thus, a therapeutically effective means of lowering levels of plasma cholesterol is by increasing the conversion of LDL cholesterol to bile acids. This can be accomplished by increasing the hepatic uptake of LDL through the hepatic LDL receptor (29) . Recently, several pharmacological agents have been reported that are capable of inducing the hepatic LDL receptor in experimental animals: pharmacological doses of 17a-ethinyl estradiol in rats (5, 6) , large doses of 3-hydroxy-3-methyglutaryl-CoA reductase inhibitors like mevinolin and compactin (30, 31) in swine (7) , cholestyramine in rabbits (17) , and a combination of mevinolin and colestipol in dogs (9) . Recent observations that mevinolin also reduces plasma cholesterol levels in rabbits fed the wheat starch/casein diet (32) suggest that mevinolin alone or in combination with cholestyramine induces hepatic LDL receptor levels in this model.
Our results show that cholestyramine lowers plasma cholesterol levels in rabbits with endogenous induced hypercholesterolemia by promoting the hepatic catabolism of 125I-LDL and suggest that the rabbit is a suitable animal model for studying the mechanism of action of hypocholesterolemic agents.
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